Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Mallinckrodt
Moodys
Johnson and Johnson
Boehringer Ingelheim

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

Litigation Details for NOVARTIS AG v. KAPPOS (D.C. 2011)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

NOVARTIS AG v. KAPPOS (D.C. 2011)

Docket   Start Trial Date Filed 2011-05-03
Court District Court, District of Columbia Date Terminated 2012-02-17
Cause 35:145 Patent Infringement Assigned To Ellen Segal Huvelle
Jury Demand None Referred To
Parties DAVID J. KAPPOS; NOVARTIS AG; NOVARTIS CORPORATION
Patents 7,097,827; 7,442,388; 7,516,741
Attorneys Carl Ezekiel Ross; Daniel James Kelly
Firms McCarter & English LLP; U.S. Attorney's Office for the District of Columbia
Link to Docket External link to docket
Small Molecule Drugs cited in NOVARTIS AG v. KAPPOS
The small molecule drug covered by the patents cited in this case is   Start Trial .
Biologic Drugs cited in NOVARTIS AG v. KAPPOS
The biologic drug covered by the patents cited in this case is   Start Trial .

Details for NOVARTIS AG v. KAPPOS (D.C. 2011)

Date Filed Document No. Description Snippet Link To Document
2011-05-03 1 of U.S. Patent No. 7,081,532; U.S. Patent No. 7,097,827; U.S. Patent No. 7,253,257; U.S. Patent No. 7,323,451…; U.S. Patent No. 7,442,388; U.S. Patent No. 7,516,741; U.S. Patent No. 7,687,637; U.S. Patent No. 7,696,216…each of these patents is summarized in Exhibit A. Patent Term Guarantee ll. The Patent Term Guarantee…,696,216; and U.S. Patent No. 7,776,851 (collectively, the “Novartis Patents”) for review of the determination… § 154(b)(3)(B), of the patent term adjustment of each of the Novartis Patents. Novartis Seeks a judgment External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Express Scripts
Harvard Business School
McKesson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.